Updates

GHO Capital announces final close of Fund III with over €2 billion of capital to invest

c.€5bn AUM positions GHO as Europe’s Reference Investor in global healthcare Significantly oversubscribed Fund closes within four months of entering the market GHO welcomes new team hires, the addition of Operating Partners and announces the opening of US office in Research Triangle Park (North Carolina) in H2 2021 London, UK – GHO Capital (Global Healthcare… read more

Velocity Clinical Research not slowing down, buying two new US sites amid own acquisition

Bicoastal expansion — New York and California London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company, Velocity Clinical, regarding the additon of two new sites to its US network. Leading US-based integrated site company, Velocity Clinical Research, today announces it has… read more

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company, Ardena, regarding a major investment to expand across Belgium, Sweden and The Netherlands. Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), in partnership with GHO Capital, announced… read more

Subscribe to our email alerts

Email updates